A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/08 (2006.01) A61K 41/00 (2006.01)
Patent
CA 2413328
The present invention describes novel compounds of the formula (I):(Q)d-Ln-Ch, useful for the diagnosis and treatment of cancer in combination therapy in a patient. The present invention provides novel compounds useful for the treatment of rheumatoid arthritis. The pharmaceuticals are comprised of a targeting moiety that binds to a receptor that is upregulated during angiogenesis, an optional linking group, and a therapeutically effective radioisotope or diagnostically effective imageable moiety
L'invention concerne des composés de formule (I):(Q)¿d?-L¿n?-C¿h?, (I):utiles pour le diagnostic et le traitement de cancer en thérapie de combinaison chez un patient. Elle concerne des composés utiles dans le traitement de l'arthrite rhumatoïde. Les produits pharmaceutiques sont constitués d'une entité de ciblage qui se lie à un récepteur qui est régulé positivement durant l'angiogénèse, éventuellement d'un groupe de liaison, et d'un radio-isotope efficace sur le plan thérapeutique ou d'une entité à imagerie efficace sur le plan du diagnostic.
Barrett John A.
Carpenter Alan P. Jr.
Edwards D. Scott
Harris Thomas D.
Heminway Stuart J.
Bristol-Myers Squibb Pharma Company
Gowling Lafleur Henderson Llp
LandOfFree
Pharmaceuticals for the imaging of angiogenic disorders for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceuticals for the imaging of angiogenic disorders for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceuticals for the imaging of angiogenic disorders for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1939687